Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Hellamand P, van de Sande MGH, Nurmohamed MT, van Vollenhoven RF, Hollick RJ, Rotariu O, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Michelsen B, Kvien TK, Glintborg B, Hetland ML, Østergaard M, Loft AG, Pavelka K, Zavada J, Castrejon I, Otero-Varela L, Gudbjornsson B, Palsson O, Olofsson T, Wallman JK, Ciurea A, Nissen MJ, Yildirim TD, Onen F, Codreanu C, Mogosan C, Santos MJ, Vieira-Sousa E, Iannone F, Frediani B, Ørnbjerg LM, Twisk JWR, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: castrejon i. Rheumatology (Oxford). 2024 Jul 23:keae370. doi: 10.1093/rheumatology/keae370. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39041780
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Hellamand P, van de Sande MGH, Ørnbjerg LM, Klausch T, Eklund KK, Relas H, Santos MJ, Vieira-Sousa E, Loft AG, Glintborg B, Østergaard M, Lindström U, Wallman JK, Michelsen B, Fagerli KM, Castrejón I, Gudbjornsson B, Love TJ, Vencovský J, Nekvindová L, Rotar Ž, Tomšič M, Díaz-González F, Kenar G, Tuğsal HY, Iannone F, Ramonda R, Codreanu C, Mogosan C, Nissen MJ, Möller B, Hetland ML, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: castrejon i. Arthritis Rheumatol. 2024 Apr;76(4):587-598. doi: 10.1002/art.42758. Epub 2024 Feb 25. Arthritis Rheumatol. 2024. PMID: 37975166
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Linde L, Georgiadis S, Ørnbjerg LM, Rasmussen SH, Michelsen B, Askling J, Di Giuseppe D, Wallman JK, Závada J, Pavelka K, Bernardes M, Matos CO, Glintborg B, Loft AG, Nordström D, Kuusalo L, Möller B, Nissen MJ, Codreanu C, Mogosan C, Gudbjornsson B, Love TJ, Akleylek C, Iannone F, Kvien TK, Rotar Z, Castrejon I, Macfarlane GJ, Hetland ML, Østergaard M. Linde L, et al. Among authors: castrejon i. Arthritis Care Res (Hoboken). 2024 Jun 26. doi: 10.1002/acr.25396. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 38926900
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry.
Fernández-Carballido C, Sanchez-Piedra C, Valls R, Garg K, Sánchez-Alonso F, Artigas L, Mas JM, Jovaní V, Manrique S, Campos C, Freire M, Martínez-González O, Castrejón I, Perella C, Coma M, van der Horst-Bruinsma IE. Fernández-Carballido C, et al. Among authors: castrejon i. Arthritis Care Res (Hoboken). 2023 Jan;75(1):115-124. doi: 10.1002/acr.25048. Epub 2022 Dec 9. Arthritis Care Res (Hoboken). 2023. PMID: 36278846
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.
Hernández-Cruz B, Otero-Varela L, Freire-González M, Busquets-Pérez N, García González AJ, Moreno-Ramos M, Blanco-Madrigal JM, Manrique-Arija S, Perez-Pampin E, Ruiz-Montesino D, Sánchez-Alonso F, Sanchez-Piedra C, Castrejón I; BIOBADASER Study Group. Hernández-Cruz B, et al. Among authors: castrejon i. Ann Rheum Dis. 2024 Aug 27;83(9):1189-1199. doi: 10.1136/ard-2023-225271. Ann Rheum Dis. 2024. PMID: 38594056 Free article.
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
Calvo-Gutiérrez J, López-Medina C, Otero-Varela L, Escudero-Contreras A, Ortega-Castro R, Ladehesa-Pineda L, Campos C, Bernabeu-Gonzalvez P, Pérez-Gómez A, García-Dorta A, Ruiz-Montesino D, Pombo-Suarez M, Ros-Vilamajo I, Sánchez-Alonso F, Castrejón I. Calvo-Gutiérrez J, et al. Among authors: castrejon i. Arthritis Res Ther. 2024 Feb 23;26(1):57. doi: 10.1186/s13075-024-03287-9. Arthritis Res Ther. 2024. PMID: 38395899 Free PMC article.
126 results